TECHWIRE 30
(CIX: WRAL30)  1,017.68    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: Apple)  95.01    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NY: QUINTILES)  55.91    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(OP: BASF SE)  64.65    (0 %)  Updated: 05:20 PM EST, Feb 08 2016
(NQ: BioCryst)  1.78    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: BioDelivery)  3.72    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: CEMP)  17.03    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: Cisco)  22.93    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: Cree)  28.93    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: DARA)  0.88    (0 %)  Updated: 08:10 PM EST, Dec 04 2015
(NY: EMC)  24.20    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(NQ: Extreme Networks)  2.51    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: Facebook)  99.75    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NY: GLAXOSMITHKLINE)  39.47    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(NQ: Alphabet)  682.74    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NY: IBM)  126.98    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(NY: LH)  100.94    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(OP: Lenovo Group)  16.68    (0 %)  Updated: 05:20 PM EST, Feb 08 2016
(NY: MRK)  48.83    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(NQ: Microsoft)  49.41    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: NetApp)  22.35    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NY: NOVARTIS AG)  73.18    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(OP: Novozymes A/S)  40.93    (0 %)  Updated: 05:20 PM EST, Feb 08 2016
(NY: Pfizer)  28.56    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(NQ: Pozen)  5.94    (0 %)  Updated: 08:10 PM EST, Feb 05 2016
(NY: Red Hat)  60.93    (0 %)  Updated: 06:40 PM EST, Feb 08 2016
(NQ: BBRY)  6.80    (0 %)  Updated: 08:10 PM EST, Feb 08 2016
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  12.55    (0 %)  Updated: 08:10 PM EST, Feb 08 2016

Posts tagged “N.C. Biotech Center”

2:07 p.m. yesterday

WTW wants you involved: Send your news - and your opinions

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated February 5

$43B Syngenta sale to ChemChina could benefit North Carolina

"ChemChina has demonstrated a strategic and pragmatic approach with other investments the company has made in U.S. operations," says N.C. Biotechnology Center exec. "We expect that as a result, it will continue to value the advantages provided within North Carolina, as the largest cluster of high-tech agriculture in the world."

Syngenta's new lab in RTP Syngenta's new lab in RTP

Updated February 5

NC Biotechnology Center awards $1.6M in grants, loans

Biotech     ​The North Carolina Biotechnology Center awarded more than $1.63 million in 18 loans and grants to propel the life science sector statewide during the last quarter of 2015. Among the total is almost $600,000 awarded through the new Biotechnology Innovation Grant program.

February 1

Durham, French firms team to develop dry eye treatment for companion animals

​Zoion Pharma of Durham has formed a collaboration with the French veterinary company Ceva Santé Animale to develop a treatment for eye diseases in companion animals.

Dye eye treatment coming for dogs Dye eye treatment coming for dogs

February 1

WTW wants you: Send your news - and your opinions

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

January 25

Fred Eshelman to receive CED's Life Science Leadership Award

Fred Eshelman   Veteran entrepreneur, philanthropist and investor Fred Eshelman will receive the Life Science Leadership Award at the 25th annual CED Life Science Conference in March.

January 25

WRAL TechWire wants you: Send your news - and your opinions

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

January 21

With Pope's blessing, Chapel Hill startup targets deadly childhood neurological diseases

Bamboo Therapeutics, a recently launched life sciences venture focusing on gene therapy to threat deadly childhood neurological disorders, received a rare emotional boost recently: A blessing from Pope Francis.

A papal blessing A papal blessing

January 19

WTW wants you: Send your news - and your opinions

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

January 14

Durham startup aims to raise $6M for blood-flow monitoring system

Durham-based Scinovia Corp.'s new imaging system to help surgeons monitor patients' blood flow during operations is moving closer to the market in 2016. And it plans to raise $6 million in capital to finance commercialization.

Real-time blood flow display system Real-time blood flow display system

January 11

Fresenius Kabi acquires BD RX plant in Wilson. signs 10-year production deal

Global health care company Fresenius Kabi has acquired BD Rx, which includes the pharmaceutical manufacturing plant in Wilson and the BD Simplist line of seven drugs in ready-to-administer prefilled glass syringes.

BR Rx plant in Wilson BR Rx plant in Wilson

January 11

We want you: Send WTW your news - and your opinions

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated January 7

Premium Lock FDA fast tracks Durham startup's prostate cancer drug

Cancer research  Less than a year after Durham drug developer Innocrin Pharmaceuticals closed on $28 million in Series D financing to fund testing of its lead cancer therapies, the company has landed a development boost from the U.S. Food and Drug Administration.

Updated January 4

Premium Lock Reviewing NC's top 2015 life science stories: The partnering deals

Biotech     North Carolina's life science community saw it all in 2015: billion-dollar deals, expansions, relocations, acquisitions, venture capital funding, an IPO, government grants, global accolades, a new pharmacy school and even two Nobel Prizes. There were a few partnering deals making headlines for North Carolina life science companies and technologies during 2015. Here's a review.

January 4

Premium Lock Contributions wanted: Send WTW your news - and your opinions

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

Updated January 1

Premium Lock Review NC's top life science stories in 2015: The acquisitions

money sign Acquisitions were a huge part of the past year in life science across North Carolina. Here's a review of the big deals.

Updated December 31, 2015

Premium Lock Reviewing NC's top life science stories in 2015: Awards, grants

DNA       Federal research grants and loans from the North Carolina Biotech Center helped fuel growth in the state's life science communities over 2015. Here's a review.

Updated December 31, 2015

Premium Lock Medical device startup Akros Medical raising $1.4M round

Akros Medical Having already secured credibility in part through a loan from the North Carolina Biotechnology Center, Durham medical device startup Akros Medical is raising capital and already has a gaggle of investors.

Updated December 30, 2015

Premium Lock Reviewing NC's top life science stories in 2015: $500M-plus in funding

Looking for cash? North Carolina's life science community saw it all in 2015: billion-dollar deals, expansions, relocations, acquisitions, venture capital funding, an IPO, government grants, global accolades, a new pharmacy school and even two Nobel Prizes. Companies also raised a lot of money. Here's a review.

Updated December 29, 2015

Premium Lock Reviewing NC's top life science stories in 2015: The expansions

New jobs     North Carolina's life science community saw it all in 2015: billion-dollar deals, expansions, relocations, acquisitions, venture capital funding, an IPO, government grants, global accolades, a new pharmacy school and even two Nobel Prizes. Here's a look at the big expansions.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith